Speech and Voice Outcomes Following HD-tDCS Over the Left SMA

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Pharmaceutical and neurosurgical treatments reliably ameliorate the cardinal motor symptoms in PD but, they often yield inconsistent outcomes for speech and voice disorders, with some studies showing exacerbation of pre-treatment deficits. Therefore, it is crucial to develop and optimize novel approaches that could simultaneously improve speech and voice deficits in PD and facilitate existing behavioral interventions. This project will investigate the immediate and short-term effects of multiple sessions of HD-tDCS over the left SMA on speech and voice deficits in PD.
Epistemonikos ID: 6f4c84993b09cf5d61cfa914a4195fa9434938f0
First added on: May 15, 2024